Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial. - Ehinger, Erik; Darabi, Anna; Visse, Edward; Edvardsson, Charlotte; Tomasevic, Gregor; Cederberg, David; Kinhult, Sara; Rydelius, Anna; Nilsson, Christer; Belting, Mattias; Bengzon, Johan; Siesjö, Peter (Trials, 2025)